JP2021504348A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504348A5 JP2021504348A5 JP2020528244A JP2020528244A JP2021504348A5 JP 2021504348 A5 JP2021504348 A5 JP 2021504348A5 JP 2020528244 A JP2020528244 A JP 2020528244A JP 2020528244 A JP2020528244 A JP 2020528244A JP 2021504348 A5 JP2021504348 A5 JP 2021504348A5
- Authority
- JP
- Japan
- Prior art keywords
- defensin
- human
- pharmaceutical composition
- defensins
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17203527 | 2017-11-24 | ||
| EP17203527.1 | 2017-11-24 | ||
| EP18191954.9 | 2018-08-31 | ||
| EP18191954 | 2018-08-31 | ||
| PCT/EP2018/082022 WO2019101773A2 (en) | 2017-11-24 | 2018-11-21 | Prevention and treatment of graft-versus-host-disease with defensins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021504348A JP2021504348A (ja) | 2021-02-15 |
| JP2021504348A5 true JP2021504348A5 (https=) | 2022-01-04 |
| JP7423523B2 JP7423523B2 (ja) | 2024-01-29 |
Family
ID=64308771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020528244A Active JP7423523B2 (ja) | 2017-11-24 | 2018-11-21 | ディフェンシンによる移植片対宿主病の予防と治療 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20200291082A1 (https=) |
| EP (1) | EP3713590B1 (https=) |
| JP (1) | JP7423523B2 (https=) |
| KR (1) | KR20200097251A (https=) |
| CN (1) | CN111741762A (https=) |
| AU (1) | AU2018371948A1 (https=) |
| BR (1) | BR112020010180A2 (https=) |
| CA (1) | CA3083315A1 (https=) |
| ES (1) | ES3038390T3 (https=) |
| MX (1) | MX2020005370A (https=) |
| PL (1) | PL3713590T3 (https=) |
| RU (1) | RU2020116903A (https=) |
| SG (1) | SG11202004207VA (https=) |
| WO (1) | WO2019101773A2 (https=) |
| ZA (1) | ZA202002669B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102244161B1 (ko) * | 2018-08-31 | 2021-04-26 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
| KR20230112561A (ko) * | 2022-01-20 | 2023-07-27 | 가톨릭대학교 산학협력단 | 간이식환자 장내균총 분석과 이를 통한 이식상태 모니터링과 면역조절 테라그노시스 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| DE4343591A1 (de) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| NZ540506A (en) * | 2002-12-19 | 2008-09-26 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| AU2009209565B2 (en) | 2008-02-01 | 2013-09-19 | Ascendis Pharma As | Prodrug comprising a self-cleavable linker |
| WO2009113065A1 (en) * | 2008-03-13 | 2009-09-17 | Hadasit Medical Research Services & Development Ltd. | Immuno-modulating compositions for the treatment of immune-mediated disorders |
| SG172709A1 (en) | 2008-07-18 | 2011-07-28 | Novozymes Adenium Biotech As | Treatment of inflammatory bowel diseases with mammal beta defensins |
| KR101722961B1 (ko) | 2009-02-11 | 2017-04-04 | 알부메딕스 에이/에스 | 알부민 변이체 및 접합체 |
| JP6219277B2 (ja) * | 2011-07-08 | 2017-10-25 | ディフェンシン セラピューティクス アンパルトセルスカブＤｅｆｅｎｓｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ａｐｓ | 炎症性腸疾患の経口治療 |
| WO2016086161A1 (en) * | 2014-11-25 | 2016-06-02 | Memorial Sloan-Kettering Cancer Center | Intestinal microbiota and gvhd |
| CN104971343B (zh) * | 2015-07-13 | 2018-02-02 | 韩源平 | 防御素在制备治疗代谢综合征药物方面的应用 |
| BR112018015170A2 (pt) * | 2016-01-26 | 2018-12-18 | Defensin Therapeutics Aps | métodos para tratamento de doenças, para promoção de crescimento magro, para tratamento ou normalização de uma microbiota disbiótica no intestino, para aumentar riqueza gênica da microbiota intestinal, para aumentar número de filos da microbiota intestinal, para aumentar produção de ácidos graxos de cadeia curta da microbiota intestinal/metaboloma, para aumentar número de bactérias, para diminuir número de bactérias, defensina a, defensina ss, ou um fragmento bioativo das mesmas, e, defensina a e/ou defensina ss e/ou um glp-1/análogo de glp-1. |
| MX2020004863A (es) * | 2017-11-10 | 2020-10-14 | Defensin Therapeutics Aps | Maduracion de la defensa de la mucosa y/o funcion intestinal/pulmonar en el bebe prematuro. |
-
2018
- 2018-11-21 PL PL18803442.5T patent/PL3713590T3/pl unknown
- 2018-11-21 EP EP18803442.5A patent/EP3713590B1/en active Active
- 2018-11-21 WO PCT/EP2018/082022 patent/WO2019101773A2/en not_active Ceased
- 2018-11-21 BR BR112020010180-0A patent/BR112020010180A2/pt not_active IP Right Cessation
- 2018-11-21 RU RU2020116903A patent/RU2020116903A/ru unknown
- 2018-11-21 AU AU2018371948A patent/AU2018371948A1/en not_active Abandoned
- 2018-11-21 JP JP2020528244A patent/JP7423523B2/ja active Active
- 2018-11-21 CN CN201880076137.1A patent/CN111741762A/zh active Pending
- 2018-11-21 US US16/765,746 patent/US20200291082A1/en not_active Abandoned
- 2018-11-21 CA CA3083315A patent/CA3083315A1/en active Pending
- 2018-11-21 KR KR1020207015412A patent/KR20200097251A/ko not_active Ceased
- 2018-11-21 ES ES18803442T patent/ES3038390T3/es active Active
- 2018-11-21 MX MX2020005370A patent/MX2020005370A/es unknown
- 2018-11-21 SG SG11202004207VA patent/SG11202004207VA/en unknown
-
2020
- 2020-05-12 ZA ZA2020/02669A patent/ZA202002669B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dutta et al. | Mammalian antimicrobial peptides: promising therapeutic targets against infection and chronic inflammation | |
| US9217021B2 (en) | Oral treatment of inflammatory bowel disease | |
| CN103476933B (zh) | 白介素1受体的拮抗剂 | |
| Gionchetti et al. | Probiotics—role in inflammatory bowel disease | |
| EP3407905A1 (en) | Methods for modulating intestinal microbiota | |
| CN1520309A (zh) | 治疗口腔及食道损伤的方法和组合物 | |
| BRPI0924481A2 (pt) | Uso de uma beta defensina de mamífero, e, método para tratar uma doença intestinal inflamatória | |
| JP2020512287A (ja) | 肺の炎症性疾患を処置するための方法 | |
| Hamed | Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy | |
| JP2021504348A5 (https=) | ||
| ES3057685T3 (en) | Treatment of liver, biliary tract and pancreatic disorders with defensins | |
| RU2020116903A (ru) | Профилактика и лечение реакции "трансплантат против хозяина" с помощью дефензинов | |
| US20240158798A1 (en) | Non-viral gene/carrier complex for prevention or treatment of acute inflammatory disease | |
| WO2010081492A1 (en) | Melanocortin analogs with antimicrobial activity | |
| JP2023116456A (ja) | 強皮症関連血管障害を治療または改善するための組成物および方法 | |
| EP3535401B1 (en) | Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes cystatin, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same | |
| CN116437938A (zh) | 肽制剂及其使用方法 | |
| ZeNNAmI et al. | A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system | |
| WO2001052901A1 (en) | Drugs for gene therapy | |
| EP4295843A1 (en) | Compositions comprising amino acids for use in the prevention and/or treatment of intestinal diseases | |
| Cheng et al. | Delivery of contraceptives to men: lesson from other therapeutic drugs | |
| Füchtbauer et al. | Glucose-metabolism is altered after loss of L-and α-cells, but not influenced by loss of K-cells 2 | |
| HK40001163B (en) | Methods for modulating intestinal microbiota | |
| HUP0303798A2 (hu) | Az UK114 fehérjének vagy fragmenseinek alkalmazása az endotoxin-sokk kezelésére és megelőzésére |